Therapy resistance, metastasis, and relapse are the major obstacles to the complete cure of cancer. These properties are believed to be conducted by cancer-associated stem cells (CSCs), which utilize developmental pathways to drive self-renewal and plasticity. The special research focus of the Pluripotency & Cancer Laboratory is to understand the activation of the embryonic program in cancer progression. The ultimate aim is to boost the development of cancer diagnostics and therapies. Our research combines quantitative proteomics and high-resolution sequencing techniques with cutting-edge stem cell techniques. The research group is led by Adj. Professor Elisa Närvä.

Read more: https://narvalab.utu.fi/